Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Y Jeng

Showing results (81-90 of 100) with videos related to

Pageof 10
Sort By:
Journal of Cardiovascular Pharmacology|November 15, 2000
Design and synthesis of a potent and selective endothelin-converting enzyme inhibitor, CGS 35066A Y Jeng, S De Lombaert, M E Beil, et al.
Journal of Neurosurgery|November 1, 1996
Systemic administration of an inhibitor of endothelin-converting enzyme for attenuation of cerebral vasospasm following experimental subarachnoid hemorrhageH H Caner, A L Kwan, A Arthur, et al.
Annals of the New York Academy of Sciences|July 23, 1999
Effect of matrix metalloproteinase inhibition on progression of atherosclerosis and aneurysm in LDL receptor-deficient mice overexpressing MMP-3, MMP-12, and MMP-13 and on restenosis in rats after balloon injuryM F Prescott, W K Sawyer, J Von Linden-Reed, et al.
Journal of Cardiovascular Pharmacology|November 15, 2000
Effects of endothelin-converting enzyme inhibitors on hemolysate-induced morphological changes and production of endothelin-1 in bovine cerebrovascular endothelial cellsA L Kwan, C L Lin, C Z Chang, et al.
Acta Neurochirurgica|February 28, 2002
Alteration of ischemic reperfusion injury in the rat neocortex by a potent antioxidant mexiletineC-Z Chang, D Winardi, J-K Loh, et al.
Peptides|January 1, 1988
Identification of protease 3.4.24.11 as the major atrial natriuretic factor degrading enzyme in the rat kidneyJ L Sonnenberg, Y Sakane, A Y Jeng, et al.
Journal of Neurosurgery|August 1, 1997
Prevention and reversal of cerebral vasospasm by an endothelin-converting enzyme inhibitor, CGS 26303, in an experimental model of subarachnoid hemorrhageA L Kwan, M Bavbek, A Y Jeng, et al.
The American Journal of Physiology|August 1, 1993
Substance P levels in experimental ileitis in guinea pigs: effects of misoprostolM J Miller, H Sadowska-Krowicka, A Y Jeng, et al.
Journal of Medicinal Chemistry|August 2, 1996
Mercaptoacyl dipeptides as orally active dual inhibitors of angiotensin-converting enzyme and neutral endopeptidaseC A Fink, J E Carlson, P A McTaggart, et al.
Neurosurgery|August 16, 2001
Continuous intravenous infusion of CGS 26303, an endothelin-converting enzyme inhibitor, prevents and reverses cerebral vasospasm after experimental subarachnoid hemorrhageA L Kwan, C L Lin, C Z Chang, et al.
Pageof 10

Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
Journal of Cardiovascular Pharmacology|November 15, 2000
Design and synthesis of a potent and selective endothelin-converting enzyme inhibitor, CGS 35066A Y Jeng, S De Lombaert, M E Beil, et al.
Journal of Neurosurgery|November 1, 1996
Systemic administration of an inhibitor of endothelin-converting enzyme for attenuation of cerebral vasospasm following experimental subarachnoid hemorrhageH H Caner, A L Kwan, A Arthur, et al.
Annals of the New York Academy of Sciences|July 23, 1999
Effect of matrix metalloproteinase inhibition on progression of atherosclerosis and aneurysm in LDL receptor-deficient mice overexpressing MMP-3, MMP-12, and MMP-13 and on restenosis in rats after balloon injuryM F Prescott, W K Sawyer, J Von Linden-Reed, et al.
Journal of Cardiovascular Pharmacology|November 15, 2000
Effects of endothelin-converting enzyme inhibitors on hemolysate-induced morphological changes and production of endothelin-1 in bovine cerebrovascular endothelial cellsA L Kwan, C L Lin, C Z Chang, et al.
Acta Neurochirurgica|February 28, 2002
Alteration of ischemic reperfusion injury in the rat neocortex by a potent antioxidant mexiletineC-Z Chang, D Winardi, J-K Loh, et al.
Peptides|January 1, 1988
Identification of protease 3.4.24.11 as the major atrial natriuretic factor degrading enzyme in the rat kidneyJ L Sonnenberg, Y Sakane, A Y Jeng, et al.
Journal of Neurosurgery|August 1, 1997
Prevention and reversal of cerebral vasospasm by an endothelin-converting enzyme inhibitor, CGS 26303, in an experimental model of subarachnoid hemorrhageA L Kwan, M Bavbek, A Y Jeng, et al.
The American Journal of Physiology|August 1, 1993
Substance P levels in experimental ileitis in guinea pigs: effects of misoprostolM J Miller, H Sadowska-Krowicka, A Y Jeng, et al.
Journal of Medicinal Chemistry|August 2, 1996
Mercaptoacyl dipeptides as orally active dual inhibitors of angiotensin-converting enzyme and neutral endopeptidaseC A Fink, J E Carlson, P A McTaggart, et al.
Neurosurgery|August 16, 2001
Continuous intravenous infusion of CGS 26303, an endothelin-converting enzyme inhibitor, prevents and reverses cerebral vasospasm after experimental subarachnoid hemorrhageA L Kwan, C L Lin, C Z Chang, et al.
Pageof 10